Form 4: Cytek Biosciences Executive Valerie Barnett Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Valerie Barnett, Chief Legal Officer of Cytek Biosciences, reports transactions involving restricted stock units and common stock, resulting in adjustments to her beneficial ownership.
Summary
- On May 20, 2024, Valerie Barnett, Chief Legal Officer of Cytek Biosciences, engaged in transactions involving Cytek Biosciences' common stock and restricted stock units (RSUs).
- Barnett acquired shares through the vesting of RSUs and disposed of shares to cover tax obligations.
- Specifically, 2,016, 2,454, and 5,156 shares were acquired through RSU vesting.
- A total of 786, 956, and 2,009 shares were disposed of at a price of $5.96 to satisfy tax withholding requirements.
- Following these transactions, Barnett's direct ownership of common stock is 42,044 shares.
- Barnett also holds 118,606 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by an executive, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and does not necessarily indicate a significant trend or event for Cytek Biosciences or the broader industry.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they relate to executive compensation and do not significantly alter the company's financial position.
Key Dates
| Date | Description |
|---|---|
| 05/18/2022 | Initial vesting date for some of the RSU awards. |
| 05/18/2023 | Vesting date for some of the RSU awards. |
| 05/18/2024 | Vesting date for some of the RSU awards. |
| 05/20/2024 | Date of the reported transactions (RSU vesting and tax withholding). |
| 05/22/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.